Phio Pharmaceuticals Announces Strategic Initiative to Create Awareness of the Comprehensive INTASYL siRNA Portfolio
- Robert Infarinato named VP, Strategic Development- Lisa Carson named as new VP, Finance and AdministrationMarlborough, Massachusetts--(Newsfile Corp. - June 6, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to treat cancer. Phio announced today a...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-06-06 7:45 AM EDT | Phio Pharmaceuticals Corp.
Neural's Partner CWE to Open Store No. 16 in the City of Bonn and Invitation to Meet Hanf.com at Mary Jane Berlin 2025
Toronto, Ontario--(Newsfile Corp. - June 6, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic drugs for mental illnesses related to substance use disorders, and CWE European Holdings Inc. ("CWE"), operating as Hanf.com, one of the Germany's...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-06-06 7:30 AM EDT | Neural Therapeutics Inc.
Mobile-health Network Solutions Announces Share Repurchase Program of up to 214,000 Shares
Singapore, Singapore--(Newsfile Corp. - June 5, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or "the Company"), a leading MedTech innovator ranked among Asia-Pacific's high-growth companies, today announced that its Board of Directors approved a share repurchase program with authorization to purchase up to 214,000 Class A Ordinary Shares ("Share...
2025-06-05 8:30 AM EDT | Mobile-health Network Solutions
Restart Life Introduces BrainBalls(TM) Product Line
Vancouver, British Columbia--(Newsfile Corp. - June 5, 2025) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce the forthcoming launch of BrainBalls™, a functional wellness snack developed in collaboration with Brain Balls Inc. through a strategic joint venture...
Technology, Biotechnology, Health
2025-06-05 8:00 AM EDT | Restart Life Sciences Corp.
Therma Bright Proposes to Amend Certain Warrants and Negotiates Debt Settlements
Toronto, Ontario--(Newsfile Corp. - June 5, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma Bright" or the "Company") a developer and investment partner specializing in advanced diagnostic and medical device technologies, announces that subject to the approval of the TSX Venture Exchange (the "TSXV"), the Company...
Technology, Biotechnology, Health
2025-06-05 7:12 AM EDT | Therma Bright Inc.
Beyond Medical Technologies Closes First Tranche of Convertible Note Financing for $1.68 Million and Announces Rebranding to Republic Technologies
Vancouver, British Columbia--(Newsfile Corp. - June 4, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") is pleased to announce the closing of the first tranche of its non-brokered private placement (the "Financing") for aggregate gross proceeds of CAD $1,680,000 (the...
Technology, Pharmaceuticals, Health
2025-06-04 5:55 PM EDT | Beyond Medical Technologies Inc.
BioHarvest Launches Informed Sport-Certified VINIA DailyChews 2X Formula for Athletes and People with Active Lifestyles
Rehovot, Israel--(Newsfile Corp. - June 4, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced the launch of VINIA® DailyChews 2X Formula, a first-of-its-kind chew designed to increase nitric oxide production and arterial dilation,...
Biotechnology, Pharmaceuticals, Health
2025-06-04 7:00 AM EDT | BioHarvest Sciences Inc.
St. Baldrick's Foundation Launches June Campaign to Honor Childhood Cancer Survivors and Support Lifesaving Research
Los Angeles, California--(Newsfile Corp. - June 3, 2025) - This National Cancer Survivor Month, St. Baldrick's Foundation, the largest charity funder of childhood cancer research grants in the U.S., is proud to launch its June campaign, "Their Next Chapter Starts With You." This powerful initiative honors the resilience of childhood...
2025-06-03 12:00 PM EDT | St. Baldrick's Foundation
Safe Supply Streaming Co Ltd. Announces Appointment of Geoff Benic as Chief Executive Officer
Toronto, Ontario--(Newsfile Corp. - June 3, 2025) - Safe Supply Streaming Co Ltd. (CSE: SPLY) (OTCQB: SSPLF) (FSE: QM4) ("Safe Supply"or the "Company"), a public investment and development company advancing innovation in healthcare, wellness, and emerging technologies, is pleased to announce the appointment of Geoff Benic as Chief Executive Officer...
2025-06-03 8:49 AM EDT | Safe Supply Streaming Co Ltd.
Delivra Health Brands, and Its Dream Water(R) Brand, Partners with QVC to Bring Dream Water to Online Shoppers Across the US
Vancouver, British Columbia--(Newsfile Corp. - June 2, 2025) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer packaged goods company uniquely positioned in the health and wellness sector, is pleased to announce that it has further expanded its presence in the United States by partnering...
Cannabis, Health, Cannabis Extractor, Cannabis Manufacturer
2025-06-02 5:00 PM EDT | Delivra Health Brands Inc.
Medicus Pharma Ltd. Announces Closing of $7.0 Million Public Offering
Philadelphia, Pennsylvania--(Newsfile Corp. - June 2, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) (the "Company") today announced the closing of its previously announced public offering of 2,260,000 units, on a "best-efforts" basis, at a price of $3.10 per unit. Each unit consisted of one common share of the Company and...
Banking/Financial Services, Biotechnology, Investment Banking, Health
2025-06-02 1:40 PM EDT | Medicus Pharma Ltd.
Rapid Dose Announces Completion of Share Issuance in Debt Settlement with Creditors
Burlington, Ontario--(Newsfile Corp. - June 2, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that further to its press release dated May 10, 2025, it has entered into debt settlement agreements with certain of its creditors (the "Creditors") to issue an aggregate of 1,888,237...
2025-06-02 9:10 AM EDT | Rapid Dose Therapeutics Corp.
Glow Lifetech Reports 238% YoY Revenue Growth and Near-Breakeven EBITDA in Q1 2025, Marking Third Straight Quarter of 40%+ Sequential Revenue Growth
Toronto, Ontario--(Newsfile Corp. - June 2, 2025) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to report its financial results for the first quarter ended March 31, 2025 ("Q1 2025). In Q1 2025, Glow delivered record revenue, sustained high gross margins,...
2025-06-02 7:30 AM EDT | Glow Lifetech Corp.
PreveCeutical Welcomes Dr. Deepak Sampath, PhD. as Corporate Advisor
Vancouver, British Columbia--(Newsfile Corp. - June 2, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to have appointed Dr. Deepak Sampath as a corporate advisor...
Biotechnology, Pharmaceuticals, Health
2025-06-02 7:00 AM EDT | PreveCeutical Medical Inc.
Silo Wellness to Relist as Born Defense, a National Security Investment Issuer Focused on Ending Forever Wars and Upholding the Just War Doctrine
Eugene, Oregon and Toronto, Ontario--(Newsfile Corp. - June 2, 2025) - Silo Wellness Inc. (CSE: SILO) ("Silo," or the "Company") is pleased to announce a proposed name change to "Born Defense" and a change of business to become an investment issuer focused on the defense and national security space guided...
2025-06-02 6:11 AM EDT | Silo Wellness Inc.
Defence Therapeutics Opens U.S. Laboratory in Boston-Cambridge Biotech Hub
Montreal, Quebec--(Newsfile Corp. - June 2, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a leading biotechnology company specializing in advanced endosomal escape technologies, is pleased to announce the opening of its first U.S. laboratory in the Boston-Cambridge area. This strategic expansion marks...
Biotechnology, Pharmaceuticals, Health
2025-06-02 3:15 AM EDT | Defence Therapeutics Inc.
Custom Health Enters into Definitive Agreement to Complete Business Combination with Queue Ventures
Vancouver, British Columbia--(Newsfile Corp. - May 30, 2025) - Custom Health, Inc. ("Custom Health"), a technology-enabled healthcare solutions company providing innovative products and services designed to improve the well-being of individuals across North America, has entered into a definitive arrangement agreement dated May 30, 2025 (the "Arrangement Agreement") with Queue...
Technology, Pharmaceuticals, Health
2025-05-30 5:11 PM EDT | Custom Health
Voting Results of Cosmo's 2025 AGM
Dublin, Ireland--(Newsfile Corp. - May 30, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) announced that its shareholders approved all voting items at today’s Ordinary Annual General Meeting. A total of 9,135,061 ordinary shares of the share capital of Cosmo were represented at...
Healthcare and Hospitals, Health
2025-05-30 9:10 AM EDT | Cosmo Pharmaceuticals N.V.
Medicus Pharma Ltd. Announces Pricing of $7.0 Million Public Offering
Philadelphia, Pennsylvania--(Newsfile Corp. - May 29, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) (the "Company") today announced the pricing of its public offering of 2,260,000 units, on a "best-efforts" basis, at a price of $3.10 per unit. Each unit consists of one common share of the Company and one warrant...
Banking/Financial Services, Biotechnology, Investment Banking, Health
2025-05-29 8:30 PM EDT | Medicus Pharma Ltd.
New leadership for the Canadian Institute of Actuaries in its 60th year
Ottawa, Ontario--(Newsfile Corp. - May 29, 2025) - Angelita Graham is taking on the role of President of the Canadian Institute of Actuaries (CIA), effective July 1, 2025.Graham, a Fellow of the CIA (FCIA), brings a wealth of experience to the position, having served the Institute since 2008 in multiple...
Healthcare and Hospitals, Pharmaceuticals, Health
2025-05-29 12:00 PM EDT | Canadian Institute of Actuaries / FR: Institut canadien des actuaires